Search - tctmd.com

Displaying 221 - 240 of 708

Sort: Relevancy | Date

News Conference News TCT 2019

Oral Anticoagulation After TAVR Doesn’t Reduce Ischemic Cerebral Lesions: AUREA

Michael O'Riordan

September 28, 2019

Presentation TCT 2019

Hong Kong Presents: Percutaneous Closure of Left Atrial Appendage With Thrombus in 2 Patients With Different Outcomes

Presenter: Ngai-Yin Chan

September 28, 2019

Presentation TCT 2019

Flash Debate: TAVR in the Moderate-Risk Bleeding Patient With AF ⁠— Close the LAA!

Presenter: Kishore Harjai

September 28, 2019

News Conference News TCT 2019

Transcatheter Options Best for Tricuspid Regurgitation in Matched Registry Analysis

Michael O'Riordan

September 27, 2019

Presentation TCT 2019

ICE Guidance as the Primary Strategy for LAA Closure: Technique and Data

Presenter: Mohamad Alkhouli

September 27, 2019

Presentation TCT 2019

Utility of CT for Pre-Procedural Planning and Device Selection

Presenter: Michael Rinaldi

September 27, 2019

Presentation TCT 2019

Case-Based Device Selection: Matching the Device With the Anatomy

Presenter: Reda Ibrahim

September 27, 2019

Presentation TCT 2019

Keynote Lecture: The Spectrum of LAA Closure Technology — Current and Emerging Devices

Presenter: Horst Sievert

September 27, 2019

Presentation TCT 2019

Residual Leak and Ischemic Stroke After LAA Closure: Whether to Close and if So, How?

Presenter: George Hanzel

September 27, 2019

Presentation TCT 2019

Optimal Timing for Surveillance Imaging After LAAC

Presenter: Saibal Kar

September 27, 2019

Presentation TCT 2019

Critical Appraisal of Post-LAA Closure Pharmacology and Device-Related Thrombus

Presenter: Kishore Harjai

September 27, 2019

Presentation TCT 2019

Device-Related Thrombus: Mechanisms, Management, and Implications for Device Design

Presenter: Simon Cheung-chi Lam

September 27, 2019

Presentation TCT 2019

Epicardial LAAC to Reduce Atrial Fibrillation: AMAZE Rationale and Status

Presenter: DJ Lakkireddy

September 26, 2019

Presentation TCT 2019

TAVR Followed by LAA Closure: Implications for Bleeding, Stroke, and HALT

Presenter: Fabian Nietlispach

September 26, 2019

Presentation TCT 2019

LAA Closure in Patients With Prior Intracranial Hemorrhage

Presenter: Jens Erik Nielsen-Kudsk

September 26, 2019

Presentation TCT 2019

Clinical Rationale for LAA Closure After AF Ablation

Presenter: DJ Lakkireddy

September 26, 2019

Presentation TCT 2019

Clinical Trial Design Considerations for Next-to-Market and Next-Generation LAAO Devices

Presenter: Brian Whisenant

September 26, 2019

Presentation TCT 2019

LAA Closure in the United States: Update From the NCDR LAAO Registry

Presenter: Matthew Price

September 26, 2019

Presentation TCT 2019

AMULET: Device Characteristics, Procedural Technique, Clinical Outcomes, and Ongoing Studies

Presenter: James Hermiller

September 26, 2019

Presentation TCT 2019

WATCHMAN: Device Characteristics, Procedural Technique, Clinical Outcomes, Ongoing Studies, and Evolution to WATCHMAN FLX

Presenter: Saibal Kar

September 26, 2019

Advertisement

Oral Anticoagulation After TAVR Doesn’t Reduce Ischemic Cerebral Lesions: AUREA

Hong Kong Presents: Percutaneous Closure of Left Atrial Appendage With Thrombus in 2 Patients With Different Outcomes

Flash Debate: TAVR in the Moderate-Risk Bleeding Patient With AF ⁠— Close the LAA!

Transcatheter Options Best for Tricuspid Regurgitation in Matched Registry Analysis

ICE Guidance as the Primary Strategy for LAA Closure: Technique and Data

Utility of CT for Pre-Procedural Planning and Device Selection

Case-Based Device Selection: Matching the Device With the Anatomy

Keynote Lecture: The Spectrum of LAA Closure Technology — Current and Emerging Devices

Residual Leak and Ischemic Stroke After LAA Closure: Whether to Close and if So, How?

Optimal Timing for Surveillance Imaging After LAAC

Critical Appraisal of Post-LAA Closure Pharmacology and Device-Related Thrombus

Device-Related Thrombus: Mechanisms, Management, and Implications for Device Design

Epicardial LAAC to Reduce Atrial Fibrillation: AMAZE Rationale and Status

TAVR Followed by LAA Closure: Implications for Bleeding, Stroke, and HALT

LAA Closure in Patients With Prior Intracranial Hemorrhage

Clinical Rationale for LAA Closure After AF Ablation

Clinical Trial Design Considerations for Next-to-Market and Next-Generation LAAO Devices

LAA Closure in the United States: Update From the NCDR LAAO Registry

AMULET: Device Characteristics, Procedural Technique, Clinical Outcomes, and Ongoing Studies

WATCHMAN: Device Characteristics, Procedural Technique, Clinical Outcomes, Ongoing Studies, and Evolution to WATCHMAN FLX

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content